Cart
sales@molnova.com
(Rac)-Z-Phe-Phe-FMK
CAS No. 108005-94-3
(Rac)-Z-Phe-Phe-FMK( —— )
Catalog No. M35042 CAS No. 108005-94-3
(Rac)-Z-Phe-Phe-FMK (Cathepsin L-IN-2) is a cathepsin L inhibitor that inhibits the tendency of β-amyloid to induce apoptotic changes .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 302 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(Rac)-Z-Phe-Phe-FMK
-
NoteResearch use only, not for human use.
-
Brief Description(Rac)-Z-Phe-Phe-FMK (Cathepsin L-IN-2) is a cathepsin L inhibitor that inhibits the tendency of β-amyloid to induce apoptotic changes .
-
DescriptionCathepsin L-IN-2 (Z-Phe-Phe-FMK) is a potent and irreversible cathepsin L and cathepsin B inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetCysteine Protease
-
RecptorCysteine Protease | Beta Amyloid
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number108005-94-3
-
Formula Weight462.51
-
Molecular FormulaC27H27FN2O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 42.5 mg/mL (91.89 mM; Ultrasonic )
-
SMILESO=C(OCC=1C=CC=CC1)NC(C(=O)NC(C(=O)CF)CC=2C=CC=CC2)CC=3C=CC=CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jonathan Frew, et al. Premature termination codon readthrough upregulates progranulin expression and improves lysosomal function in preclinical models of GRN deficiency. Mol Neurodegener. 2020 Mar 16;15(1):21.?
molnova catalog
related products
-
E-64
E-64 is an irreversible and selective cysteine protease inhibitor with IC50 of 9 nM for papain.
-
L 006235
L 006235 is a potent and reversible inhibitor of cathepsin K with IC50 of 0.25 nM.
-
MK-0674
MK-0674 is an orally available, selective and potent cathepsin K inhibitor (IC50: 0.4 nM) that inhibits Cat B, Cat F, Cat L, and Cat S. It can be used in metabolism-related diseases.
